Search Results - "Pampanelli, S."

Refine Results
  1. 1
  2. 2

    Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin by Porcellati, F., Rossetti, P., Pampanelli, S., Fanelli, C. G., Torlone, E., Scionti, L., Perriello, G., Bolli, G. B.

    Published in Diabetic medicine (01-11-2004)
    “…Background  Glargine is a long‐acting insulin analogue potentially more suitable than NPH insulin in intensive treatment of Type 1 diabetes mellitus (T1 DM),…”
    Get full text
    Journal Article
  3. 3

    Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes by Perriello, G., Pampanelli, S., Di Pietro, C., Brunetti, P.

    Published in Diabetic medicine (01-03-2006)
    “…Aims  To compare long‐term (1 year) efficacy and safety of pioglitazone and gliclazide in patients with Type 2 diabetes. Methods  This was a double‐blind,…”
    Get full text
    Journal Article
  4. 4

    Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime by Lalli, C, Ciofetta, M, Del Sindaco, P, Torlone, E, Pampanelli, S, Compagnucci, P, Cartechini, M G, Bartocci, L, Brunetti, P, Bolli, G B

    Published in Diabetes care (01-03-1999)
    “…Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. C Lalli , M…”
    Get full text
    Journal Article
  5. 5

    Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia by Porcellati, F, Pampanelli, S, Rossetti, P, Busciantella Ricci, N, Marzotti, S, Lucidi, P, Santeusanio, F, Bolli, G. B, Fanelli, C. G

    Published in Diabetologia (01-02-2007)
    “…Aims/hypothesis The aim of our study was to establish whether the well-known defective or absent secretion of glucagon in type 1 diabetes in response to…”
    Get full text
    Journal Article
  6. 6

    Brief elevation of hepatic enzymes due to liver ischemia in anorexia nervosa by Giordano, F., Arnone, S., Santeusanio, F., Pampanelli, S.

    Published in Eating and weight disorders (01-12-2010)
    “…Abnormal liver function is occasionally observed in patients affected by anorexia nervosa. Although numerous studies report a strong relation between…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial by Perriello, G., Pampanelli, S., Porcellati, F., Avogaro, A., Bosi, E., Petrella, G., Squatrito, S., Furneri, S., Marra, G., Vitali, L., Previti, M., Cucinotta, D.

    Published in Diabetic medicine (01-05-2005)
    “…Aims  This randomized, multi‐centre, double‐blind, stratified, two period, cross‐over trial was undertaken to assess the pharmacokinetics and pharmacodynamics…”
    Get full text
    Journal Article
  9. 9

    Factors affecting dropout in outpatient eating disorder treatment by Bandini, S, Antonelli, G, Moretti, P, Pampanelli, S, Quartesan, R, Perriello, G

    Published in Eating and weight disorders (01-12-2006)
    “…To evaluate the incidence and effects of factors potentially influencing eating disordered patients' dropping out of outpatient cognitive-behavioural therapy…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal by Sindaco, P. Del, Ciofetta, M., Lalli, C., Perriello, G., Pampanelli, S., Torlone, E., Brunetti, P., Bolli, G.B.

    Published in Diabetic medicine (01-07-1998)
    “…To establish whether lispro may be a suitable short‐acting insulin preparation for meals in intensive treatment of Type 1 diabetes mellitus (DM) in patients…”
    Get full text
    Journal Article
  12. 12

    Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect by Bottini, P., Boschetti, E., Pampanelli, S., Ciofetta, M., Del Sindaco, P., Scionti, L., Brunetti, P., Bolli, G. B.

    Published in Diabetes (New York, N.Y.) (01-05-1997)
    “…Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. P Bottini , E…”
    Get full text
    Journal Article
  13. 13

    Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM by Perriello, G., Pampanelli, S., Del Sindaco, P., Lalli, C., Ciofetta, M., Volpi, E., Santeusanio, F., Brunetti, P., Bolli, G. B.

    Published in Diabetes (New York, N.Y.) (01-06-1997)
    “…Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. G Perriello , S Pampanelli , P Del Sindaco , C Lalli , M…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM by TORLONE, E, PAMPANELLI, S, BRUNETTI, P, BOLLI, G, LALLI, C, DEL SINDACO, P, DI VINCENZO, A, RAMBOTTI, A. M, MODARELLI, F, EPIFANO, L, KASSI, G, PERRIELLO, G

    Published in Diabetes care (01-09-1996)
    “…Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. E Torlone , S Pampanelli , C Lalli , P Del…”
    Get full text
    Journal Article
  17. 17

    Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM by TORLONE, E, FANELLI, C, BOLLI, G. B, RAMBOTTI, A. M, KASSI, G, MODARELLI, F, DI VINCENZO, A, EPIFANO, L, CIOFETTA, M, PAMPANELLI, S, BRUNETTI, P

    Published in Diabetologia (01-07-1994)
    “…The aim of these studies was to compare the pharmacokinetics, pharmacodynamics, counterregulatory hormone and symptom responses, as well as cognitive function…”
    Get full text
    Journal Article
  18. 18

    Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation by Fanelli, C., Pampanelli, S., Lalli, C., Del Sindaco, P., Ciofetta, M., Lepore, M., Porcellati, F., Bottini, P., Di Vincenzo, A., Brunetti, P., Bolli, G. B.

    Published in Diabetes (New York, N.Y.) (01-07-1997)
    “…Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. C Fanelli , S…”
    Get full text
    Journal Article
  19. 19

    Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function by PAMPANELLI, S, TORLONE, E, LALLI, C, DEL SINDACO, P, CIOFETTA, M, LEPORE, M, BARTOCCI, L, BRUNETTI, P, BOLLI, G. B

    Published in Diabetes care (01-11-1995)
    “…Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic…”
    Get full text
    Journal Article
  20. 20

    Rate of fall of blood glucose and physiological responses of counterregulatory hormones, clinical symptoms and cognitive function to hypoglycaemia in Type I diabetes mellitus in the postprandial state by FANELLI, C. G, PAMPANELLI, S, PORCELLATI, F, BARTOCCI, L, SCIONTI, L, ROSSETTI, P, BOLLI, G. B

    Published in Diabetologia (2003)
    “…The aim of this study was to establish the effect of a rate of decreasing plasma glucose concentrations on responses to hypoglycaemia, i.e. release of…”
    Get full text
    Journal Article